Methods of manufacture of immunocompatible chorionic membrane products

a chorionic membrane and immunocompatibility technology, applied in the direction of biocide, drug composition, peptide/protein ingredients, etc., can solve the problems of increased risk of disease transmission, non-native cellular populations of products that are less capable of wound healing, and products with less ability to heal wounds. to achieve the effect of superior wound healing properties
US20110212063A1Inactive Publication Date: 2011-09-01OSIRIS THERAPEUTICS
28 Cites 15 Cited by

Patent Information

Authority / Receiving Office
US · United States
Patent Type
Applications(United States)
Current Assignee / Owner
OSIRIS THERAPEUTICS
Publication Date
2011-09-01
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

Provided herein is a placental product comprising an immunocompatible chorionic membrane. Such placental products can be cryopreserved and contain viable therapeutic cells after thawing. The placental product of the present invention is useful in treating a patient with a tissue injury (e.g. wound or burn) by applying the placental product to the injury. Similar application is useful with ligament and tendon repair and for engraftment procedures such as bone engraftment.
Need to check novelty before this filing date? Find Prior Art

Description

RELATED APPLICATIONS

[0001] This application claims priority to:

[0002] U.S. Provisional Application Ser. No. 61 / 338,464 entitled “Selectively Immunodepleted Chorionic Membranes”, filed on Feb. 18, 2010 bearing Docket No. 22924US01,

[0003] U.S. Provisional Application Ser. No. 61 / 338,489 entitled “Selectively Immunodepleted Amniotic Membranes”, filed on Feb. 18, 2010 bearing Docket No. 22925US01, and

[0004] U.S. Provisional Application Ser. No. 61 / 369,562 entitled “Therapeutic Products Comprising Vitalized Placental Dispersions filed on Jul. 30, 2010 bearing Docket No 23498US01, the contents of which are hereby incorporated by reference in their entireties.

[0005] This application is being co-filed on Feb. 18, 2011 with, and incorporates by reference, applications entitled:

[0006] “Methods of Manufacture of Immunocompatible Chorionic Membrane Products”,

[0007] “Immunocompatible Amniotic Membrane Products”,

[0008] “Methods of Manufacture of Immunocompatible Amniotic Membrane Products”,

[0009] “Therape...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More